Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Fulcrum Therapeutics (FULC) Long-Term Debt Repayments (2019 - 2021)

Historic Long-Term Debt Repayments for Fulcrum Therapeutics (FULC) over the last 3 years, with Q4 2021 value amounting to $1000.0.

  • Fulcrum Therapeutics' Long-Term Debt Repayments fell 9230.77% to $1000.0 in Q4 2021 from the same period last year, while for Sep 2022 it was $1000.0, marking a year-over-year decrease of 9666.67%. This contributed to the annual value of $18000.0 for FY2021, which is 6400.0% down from last year.
  • Per Fulcrum Therapeutics' latest filing, its Long-Term Debt Repayments stood at $1000.0 for Q4 2021, which was down 9230.77% from -$1000.0 recorded in Q3 2021.
  • Fulcrum Therapeutics' 5-year Long-Term Debt Repayments high stood at $13000.0 for Q3 2019, and its period low was -$1000.0 during Q3 2021.
  • Over the past 3 years, Fulcrum Therapeutics' median Long-Term Debt Repayments value was $11500.0 (recorded in 2019), while the average stood at $9416.7.
  • As far as peak fluctuations go, Fulcrum Therapeutics' Long-Term Debt Repayments surged by 2000.0% in 2020, and later tumbled by 10769.23% in 2021.
  • Fulcrum Therapeutics' Long-Term Debt Repayments (Quarter) stood at $11000.0 in 2019, then rose by 18.18% to $13000.0 in 2020, then crashed by 92.31% to $1000.0 in 2021.
  • Its Long-Term Debt Repayments stands at $1000.0 for Q4 2021, versus -$1000.0 for Q3 2021 and $5000.0 for Q2 2021.